|
Originally published In Press as doi:10.1074/jbc.M105011200 on June 18, 2001
J. Biol. Chem., Vol. 276, Issue 33, 30885-30891, August 17, 2001
Stimulation of Cytochrome P450 Reactions by Apo-cytochrome
b5
EVIDENCE AGAINST TRANSFER OF HEME FROM CYTOCHROME P450 3A4 TO
APO-CYTOCHROME b5 OR HEME OXYGENASE*
Hiroshi
Yamazaki ,
Tsutomu
Shimada§,
Martha V.
Martin¶, and
F. Peter
Guengerich¶
From the Division of Drug Metabolism, Faculty of
Pharmaceutical Sciences, Kanazawa University, Kanazawa 920-0934, Japan,
the § Osaka Prefectural Institute of Public Health, Osaka
537-0025, Japan, and the ¶ Department of Biochemistry and Center
in Molecular Toxicology, Vanderbilt University School of Medicine,
Nashville, Tennessee 37232-0146
Many cytochrome P450
(P450)-dependent reactions have been shown to be stimulated
by another microsomal protein, cytochrome b5
(b5). Two major explanations are (i) direct
electron transfer from b5 and (ii) a
conformational effect in the absence of electron transfer. Some P450s
(e.g. 3A4, 2C9, 17A, and 4A7) are stimulated by either
b5 or b5 devoid of heme
(apo-b5), indicating a lack of electron
transfer, whereas other P450s (e.g. 2E1) are stimulated by
b5 but not by apo-b5.
Recently, a proposal has been made by Guryev et al.
(Biochemistry 40, 5018-5031, 2001) that the stimulation by
apo-b5 can be explained only by transfer of
heme from P450 preparations to apo-b5, enabling
electron transfer. We have repeated earlier findings of stimulation of
catalytic activity of testosterone 6 -hydroxylation activities with
four P450 preparations, in which nearly all of the heme was accounted
for as P450. Spectral analysis of mixtures indicated that only ~5%
of the heme can be transferred to apo-b5, which
cannot account for the observed stimulation. The presence of the heme
scavenger apomyoglobin did not inhibit the stimulation of P450
3A4-dependent testosterone or nifedipine oxidation
activity. Further evidence against the presence of loosely bound P450
3A4 heme was provided in experiments with apo-heme oxygenase, in which
only 3% of the P450 heme was converted to biliverdin. Finally,
b5 supported NADH-b5
reductase/P450 3A4-dependent testosterone
6 -hydroxylation, but apo-b5 did not.
Thus, apo-b5 can stimulate P450 3A4
reactions as well as b5 in the absence of
electron transfer, and heme transfer from P450 3A4 to
apo-b5 cannot be used to explain the catalytic stimulation.
*
This research was supported in part by United States Public
Health Service Grants R35 CA44353, R01 CA90426, and P30 ES00267 and
grants from the Ministry of Education, Science, and Culture of Japan
and the Ministry of Health and Welfare of Japan.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of
Biochemistry and Center in Molecular Toxicology, Vanderbilt University School of Medicine, 638 Robinson Research Building (MRBI),
23rd and Pierce Avenues, Nashville, TN 37232-0146. Tel.:
615-322-2261; Fax: 615-322-3141; E-mail:
guengerich@toxicology.mc.vanderbilt.edu.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. D. Finn, L. A. McLaughlin, S. Ronseaux, I. Rosewell, J. B. Houston, C. J. Henderson, and C. R. Wolf
Defining the in Vivo Role for Cytochrome b5 in Cytochrome P450 Function through the Conditional Hepatic Deletion of Microsomal Cytochrome b5
J. Biol. Chem.,
November 14, 2008;
283(46):
31385 - 31393.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. N. Bumpus and P. F. Hollenberg
Investigation of the Mechanisms Underlying the Differential Effects of the K262R Mutation of P450 2B6 on Catalytic Activity
Mol. Pharmacol.,
October 1, 2008;
74(4):
990 - 999.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. W. Locuson, L. C. Wienkers, J. P. Jones, and T. S. Tracy
CYP2C9 Protein Interactions with Cytochrome b5: Effects on the Coupling of Catalysis
Drug Metab. Dispos.,
July 1, 2007;
35(7):
1174 - 1181.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Gao, C. E. Doneanu, S. A. Shaffer, E. T. Adman, D. R. Goodlett, and S. D. Nelson
Identification of the Interactions between Cytochrome P450 2E1 and Cytochrome b5 by Mass Spectrometry and Site-directed Mutagenesis
J. Biol. Chem.,
July 21, 2006;
281(29):
20404 - 20417.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Hummel, T. S. Tracy, J. M. Hutzler, J. L. Wahlstrom, Y. Zhou, and D. A. Rock
Influence of Fluorescent Probe Size and Cytochrome b5 on Drug-Drug Interactions in CYP2C9
J Biomol Screen,
April 1, 2006;
11(3):
303 - 309.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kumar, D. R. Davydov, and J. R. Halpert
ROLE OF CYTOCHROME B5 IN MODULATING PEROXIDE-SUPPORTED CYP3A4 ACTIVITY: EVIDENCE FOR A CONFORMATIONAL TRANSITION AND CYTOCHROME P450 HETEROGENEITY
Drug Metab. Dispos.,
August 1, 2005;
33(8):
1131 - 1136.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. V. Pandey and W. L. Miller
Regulation of 17,20 Lyase Activity by Cytochrome b5 and by Serine Phosphorylation of P450c17
J. Biol. Chem.,
April 8, 2005;
280(14):
13265 - 13271.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Duarte, B. B. Palma, A. A. Gilep, A. Laires, J. S. Oliveira, S. A. Usanov, J. Rueff, and M. Kranendonk
The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1: a new cell expression system to study cytochrome P450 mediated biotransformation
Mutagenesis,
March 1, 2005;
20(2):
93 - 100.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Yamaguchi, K. K. Khan, Y. A. He, Y. Q. He, and J. R. Halpert
TOPOLOGICAL CHANGES IN THE CYP3A4 ACTIVE SITE PROBED WITH PHENYLDIAZENE: EFFECT OF INTERACTION WITH NADPH-CYTOCHROME P450 REDUCTASE AND CYTOCHROME B5 AND OF SITE-DIRECTED MUTAGENESIS
Drug Metab. Dispos.,
January 1, 2004;
32(1):
155 - 161.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Stiborova, V. Martinek, H. Rydlova, P. Hodek, and E. Frei
Sudan I Is a Potential Carcinogen for Humans: Evidence for Its Metabolic Activation and Detoxication by Human Recombinant Cytochrome P450 1A1 and Liver Microsomes
Cancer Res.,
October 15, 2002;
62(20):
5678 - 5684.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. H. Hanna, J. A. Krauser, H. Cai, M.-S. Kim, and F. P. Guengerich
Diversity in Mechanisms of Substrate Oxidation by Cytochrome P450 2D6. LACK OF AN ALLOSTERIC ROLE OF NADPH-CYTOCHROME P450 REDUCTASE IN CATALYTIC REGIOSELECTIVITY
J. Biol. Chem.,
October 19, 2001;
276(43):
39553 - 39561.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|